Chimeron Bio
PrivateLast Round
VC Round
Mar 2, 2025
Total Funding Raised
$1.68M
Company Overview
Chimeron Bio is a biotechnology company that develops self-amplifying RNA (saRNA) therapeutics and vaccines intended to treat diseases including cancer, infectious diseases, and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chimeron Bio Comparables
Compare Chimeron Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ziphius Vaccines | 83% | |
| Replicate Bioscience | 83% | |
| Kernalbio | 83% |
Chimeron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 2, 2025 | ||||
| Grant | Feb 21, 2024 | ||||
| Grant | Jun 6, 2023 | ||||
| Seed | Feb 28, 2022 | ||||
| Grant | Aug 28, 2020 | ||||
Accelerator | Jun 1, 2017 |
Chimeron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Dreavent Capital | Seed |
| Alexandria Venture Investments | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 57% MoM.
- Mar 2, 2025
$14M raised in a VC Round.
Chimeron Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chimeron Bio's valuation, stock price, and market status.
Is Chimeron Bio a public or private company?
Chimeron Bio is a private company.
What is the current stock price of Chimeron Bio?
Chimeron Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Chimeron Bio worth (valuation)?
Valuation information for Chimeron Bio is not publicly available.
Can I buy Chimeron Bio stock?
Chimeron Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chimeron Bio's last funding round?
Chimeron Bio's most recent funding round was VC Round on March 2, 2025.
Who are the main investors in Chimeron Bio?
Key investors in Chimeron Bio include National Cancer Institute, Dreavent Capital, Alexandria Venture Investments.
Will Chimeron Bio IPO soon?
No public IPO plans have been announced for Chimeron Bio.
How can I track Chimeron Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chimeron Bio's secondary market activity and sign up for updates.